SCHEMBL14948995

SCHEMBL14948995

O=C(c1ccccc1)c1conc1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
KMT2A Q03164 4/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 3/20 0.46
PKM P14618 2/20 0.46
HPGD P15428 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PDE4A P27815 1/20 0.45
PTGS2 P35354 4/20 0.45
AKR1C3 P42330 1/20 0.44
CDC25B P30305 2/20 0.43
ATM Q13315 2/20 0.43
GAA P10253 1/20 0.42
ADORA1 P30542 1/20 0.41
PTPRC P08575 1/20 0.40
PTPRF P10586 1/20 0.40
PTPN1 P18031 1/20 0.40
CDC25A P30304 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1225673 0.84 PTGS2 (0.44) ALDH1A1KMT2AMEN1HPGDNPC1
SCHEMBL27934992 0.82 PTGS2 (0.43) ALDH1A1KMT2AMEN1HPGDNPC1
SCHEMBL892702 0.81 MEN1 (0.49) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL2468990 0.81 PTGS2 (0.45) ALDH1A1KMT2AMAPTMEN1SMN1; SMN2
SCHEMBL10971135 0.81 PTGS2 (0.42) ALDH1A1KMT2AMEN1HPGDNPC1
SCHEMBL11420488 0.80 NPSR1 (0.48) ALDH1A1HPGDNPC1RAB9APTGS2
SCHEMBL22245510 0.77 PTGS2 (0.52) ALDH1A1KMT2AMAPTMEN1PKM
SCHEMBL8463065 0.77 PTGS2 (0.56) ALDH1A1KMT2AMAPTMEN1PKM
SCHEMBL12297897 0.77 KMT2A (0.40) ALDH1A1KMT2AMAPTMEN1HPGD
SCHEMBL2929763 0.77 PTGS1 (0.54) ALDH1A1KMT2AMAPTMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9732050-B2 Modulators of sperm hypermotility and uses thereof HYDRA BIOSCIENCES, INC. (US) 2017-08-15 US disclosed
US-20150335622-A1 MODULATORS OF SPERM HYPERMOTILITY AND USES THEREOF HYDRA BIOSCIENCES, INC. (US) 2015-11-26 US disclosed
US-8952041-B2 Modulators of sperm hypermobility and uses thereof HYDRA BIOSCIENCES, INC. (US) 2015-02-10 US disclosed
US-20130123310-A1 MODULATORS OF SPERM HYPERMOBILITY AND USES THEREOF HYDRA BIOSCIENCES, INC. (US) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123310-A1 MODULATORS OF SPERM HYPERMOBILITY AND USES THEREOF CATSPER1, SPAG5, NASP ALDH1A1 630/4885KMT2A 1636/4885MAPT 4340/4885
US-20150335622-A1 MODULATORS OF SPERM HYPERMOTILITY AND USES THEREOF CATSPER1, SPAG5, ITPR3 ALDH1A1 807/4885KMT2A 1670/4885MAPT 4125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.